home / stock / srpt / srpt quote
Last: | $115.62 |
---|---|
Change Percent: | 0.0% |
Open: | $116.55 |
Close: | $115.62 |
High: | $117.74 |
Low: | $114.37 |
Volume: | 641,117 |
Last Trade Date Time: | 04/19/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$115.62 | $116.55 | $115.62 | $117.74 | $114.37 | 641,117 | 04-19-2024 |
$116.55 | $117.55 | $116.55 | $118.9 | $115.79 | 498,572 | 04-18-2024 |
$117.89 | $117 | $117.89 | $119.08 | $115.9301 | 546,229 | 04-17-2024 |
$117.29 | $117.6 | $117.29 | $118.69 | $116.943 | 592,917 | 04-16-2024 |
$118.31 | $122.18 | $118.31 | $122.985 | $117.78 | 860,486 | 04-15-2024 |
$122.87 | $124.17 | $122.87 | $124.82 | $121.49 | 656,117 | 04-12-2024 |
$124.45 | $127.28 | $124.45 | $127.4921 | $123.4 | 618,223 | 04-11-2024 |
$126.31 | $124.13 | $126.31 | $126.47 | $123.87 | 523,340 | 04-10-2024 |
$126.98 | $126.46 | $126.98 | $127.41 | $126.07 | 286,092 | 04-09-2024 |
$126.39 | $126.17 | $126.39 | $126.6802 | $124.37 | 559,199 | 04-08-2024 |
$126.08 | $125.43 | $126.08 | $127.64 | $123.85 | 303,511 | 04-05-2024 |
$125.79 | $127.22 | $125.79 | $128.2301 | $124.87 | 747,118 | 04-04-2024 |
$126.92 | $126.07 | $126.92 | $128.6 | $125.17 | 851,048 | 04-03-2024 |
$127 | $127.68 | $127 | $128.8 | $125.8 | 519,194 | 04-02-2024 |
$128.4 | $129.38 | $128.4 | $129.38 | $126.11 | 858,391 | 04-01-2024 |
$129.46 | $131.16 | $129.46 | $131.16 | $127.83 | 811,626 | 03-29-2024 |
$129.46 | $131.16 | $129.46 | $131.16 | $127.83 | 811,626 | 03-28-2024 |
$130.23 | $129.25 | $130.23 | $130.32 | $127.355 | 592,604 | 03-27-2024 |
$128.25 | $129.83 | $128.25 | $129.97 | $128 | 530,108 | 03-26-2024 |
$127.94 | $127 | $127.94 | $128.95 | $126 | 396,054 | 03-25-2024 |
News, Short Squeeze, Breakout and More Instantly...
Sarepta Therapeutics Inc. Company Name:
SRPT Stock Symbol:
NASDAQ Market:
Sarepta Therapeutics Inc. Website:
2024-04-06 08:45:00 ET The biotech industry can be attractive for several reasons. Many leading biotechs develop innovative, life-saving therapies, a business that will only be phased out once we find an all-purpose cure for all illnesses. Further, biotechs often deliver better-than-average...
2024-03-19 10:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-03-13 08:00:00 ET Sarepta Therapeutics (NASDAQ: SRPT) could have a serious new competitor on the horizon. According to some fresh clinical data from Regenxbio (NASDAQ: RGNX) , another biotech, the company is making headway with a gene therapy for Duchenne muscular dystr...